NCT02918955 2025-11-20
UPFRONT-NECK
Insel Gruppe AG, University Hospital Bern
Phase 3 Completed
Clinical Trials
11 trialsNCT03416153 2025-05-22
Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT03715946 2025-01-13
Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer
University of Pittsburgh
Phase 2 Completed
NCT04541355 2024-06-28
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin
University of California, San Francisco
Phase 2 Completed
NCT01711541 2023-06-07
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00964977 2022-02-25
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
Johannes Gutenberg University Mainz
Phase 3 Completed
NCT01440270 2020-05-05
Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Shanghai Jiao Tong University School of Medicine
Phase 2 Completed
NCT01064921 2019-06-04
Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT01434394 2017-08-21
EAGLE
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Completed
NCT00008398 2013-11-19
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00002951 2013-09-05
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
University of Chicago
Phase 2 Completed